UCLA Mattel Children's Hospital — Los Angeles, California

Public research footprint of UCLA Mattel Children's Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Tuberous Sclerosis Complex · Pediatric Sepsis-induced MODS · Ornithine Transcarbamylase Deficiency Disease · Sickle Cell Disease

Recently updated registry entries

NCT03386539 — Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using… (Completed)
NCT06672549 — A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) (Recruiting)
NCT06739122 — A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UCLA Mattel Children's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.